ScholarIQanswers from OpenAlex

TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy

PaperCitations, authors & open-access status

TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy have?

ScholarIQcitation count

TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy has 260 citations in the OpenAlex counts ScholarIQ stores.

When was TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy published?

ScholarIQyear

TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy has 2018 year in the ScholarIQ index.

What is the open-access status of TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy?

ScholarIQoa status

TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy has green oa status in the ScholarIQ index.

What is the DOI of TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy?

ScholarIQdoi

The DOI for TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy is on the source record.

What is the PMID of TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy?

ScholarIQpmid

The PMID for TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy is on the source record.

What is the OpenAlex record for TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy?

ScholarIQopenalex

The OpenAlex for TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial